Becton, Dickinson and Company (BDX) announced it received 510(k) clearance from the FDA for the Surgiphor 1000mL for wound irrigation. Surgiphor 1000mL provides a standardized, OR-ready solution that enhances surgical safety and efficacy. Surgiphor 1000mL arrives ready-to-use, eliminating the need for hospital staff to mix solutions by hand.
The company said the expanded Surgiphor portfolio now offers both manual and powered irrigation configurations, giving clinicians flexibility to match the needs of their workflow and patient population.
In pre-market trading on NYSE, BDX shares are down 0.27 percent to $176.00.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.